Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 17, 2006 Filed Feb 22, 2006 22:39 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantCommon shares without par value | 28,600 | $44.16 | $1,262,976.00 |
DisclosureSEC source: 0001104659-06-011222 · a4.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,042 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:41 UTC |
Binder Jeffrey RSenior Vice President
|
GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011224 · a4.xml · derivative · entry 3 Binder Jeffrey R · CIK 0001349819 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: common shares · 83,000 shares Expires 2016-02-16 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 2/17/2007, 27,667 on 2/17/2008 and 27,666 on 2/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:41 UTC |
Binder Jeffrey RSenior Vice President
|
GrantCommon shares without par value | 26,500 | $44.16 | $1,170,240.00 |
DisclosureSEC source: 0001104659-06-011224 · a4.xml · nonDerivative · entry 2 Binder Jeffrey R · CIK 0001349819 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,697 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:42 UTC |
DEMPSEY WILLIAM GSenior Vice Pesident
|
GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011225 · a4.xml · derivative · entry 5 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice Pesident 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: common shares · 83,000 shares Expires 2016-02-16 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 2/17/2007, 27,667 on 2/17/2008 and 27,666 on 2/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:42 UTC |
DEMPSEY WILLIAM GSenior Vice Pesident
|
GrantCommon shares without par value | 26,500 | $44.16 | $1,170,240.00 |
DisclosureSEC source: 0001104659-06-011225 · a4.xml · nonDerivative · entry 2 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice Pesident 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,129 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:42 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011227 · a4.xml · derivative · entry 7 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: common shares · 83,000 shares Expires 2016-02-16 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 2/17/2007, 27,667 on 2/17/2008 and 27,666 on 2/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:42 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
GrantCommon shares without par value | 26,500 | $44.16 | $1,170,240.00 |
DisclosureSEC source: 0001104659-06-011227 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,397 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:43 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 438,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011228 · a4.xml · derivative · entry 6 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 438,000 Underlying: common shares · 438,000 shares Expires 2016-02-16 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 146,000 on 2/17/07, 146,000 on 2/17/08 and 146,000 on 2/17/09. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:43 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantCommon shares without par value | 139,000 | $44.16 | $6,138,240.00 |
DisclosureSEC source: 0001104659-06-011228 · a4.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 770,690 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:45 UTC |
MCCULLOUGH GARY ESenior Vice President
|
GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011229 · a4.xml · derivative · entry 4 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: common shares · 83,000 shares Expires 2016-02-16 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 2/17/2007, 27,667 on 2/17/08, and 27,666 on 2/17/09. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:45 UTC |
MCCULLOUGH GARY ESenior Vice President
|
GrantCommon shares without par value | 26,500 | $44.16 | $1,170,240.00 |
DisclosureSEC source: 0001104659-06-011229 · a4.xml · nonDerivative · entry 1 MCCULLOUGH GARY E · CIK 0001163212 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,829 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:50 UTC |
Tyree James LSenior Vice President
|
GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011230 · a4.xml · derivative · entry 5 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: common shares · 83,000 shares Expires 2016-02-16 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 2/17/2007, 27,667 on 2/17/08, and 27,666 on 2/17/09. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:50 UTC |
Tyree James LSenior Vice President
|
GrantCommon shares without par value | 26,500 | $44.16 | $1,170,240.00 |
DisclosureSEC source: 0001104659-06-011230 · a4.xml · nonDerivative · entry 1 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,041 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:51 UTC |
LINDER GREG WVice President
|
GrantOption (right to buy) · Derivative | 36,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011231 · a4.xml · derivative · entry 5 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: common shares · 36,000 shares Expires 2016-02-16 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) Rule 16b-3. The option becomes exercisable in annual increments of 12,000 on 2/17/2007, 12,000 on 2/17/2008 and 12,000 on 2/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:51 UTC |
LINDER GREG WVice President
|
GrantCommon shares without par value | 12,500 | $44.16 | $552,000.00 |
DisclosureSEC source: 0001104659-06-011231 · a4.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,333 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:52 UTC |
Fiorentino Edward JSenior Vice President
|
GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011232 · a4.xml · derivative · entry 5 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common Shares · 83,000 shares Expires 2016-02-16 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/17/2007, 27,667 on 02/17/2008 and 27,666 on 02/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:52 UTC |
Fiorentino Edward JSenior Vice President
|
GrantCommon shares without par value | 26,500 | $44.16 | $1,170,240.00 |
DisclosureSEC source: 0001104659-06-011232 · a4.xml · nonDerivative · entry 2 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,403 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:55 UTC |
Fussell Stephen RSenior Vice President
|
GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011233 · a4.xml · derivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common shares · 83,000 shares Expires 2016-02-16 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/17/2007, 27,667 on 02/17/2008 and 27,666 on 02/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:55 UTC |
Fussell Stephen RSenior Vice President
|
GrantCommon shares without par value | 26,500 | $44.16 | $1,170,240.00 |
DisclosureSEC source: 0001104659-06-011233 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,483 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:56 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011234 · a4.xml · derivative · entry 7 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common shares · 83,000 shares Expires 2016-02-16 F6 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/17/2007, 27,667 on 02/17/2008 and 27,666 on 02/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:56 UTC |
Landgraf John CSenior Vice President
|
GrantCommon shares without par value | 26,500 | $44.16 | $1,170,240.00 |
DisclosureSEC source: 0001104659-06-011234 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,985 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:58 UTC |
LEIDEN JEFFREY MDirector · President and COO
|
GrantOption (right to buy) · Derivative | 310,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011235 · a4.xml · derivative · entry 5 LEIDEN JEFFREY M · CIK 0001242825 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,000 Underlying: Common shares · 310,000 shares Expires 2016-02-16 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 103,334 on 02/17/2007, 103,333 on 02/17/2008 and 103,333 on 02/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:58 UTC |
LEIDEN JEFFREY MDirector · President and COO
|
SaleCommon shares without par value | 2,000 | $44.41 | $88,820.00 |
DisclosureSEC source: 0001104659-06-011235 · a4.xml · nonDerivative · entry 3 LEIDEN JEFFREY M · CIK 0001242825 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401,247 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:58 UTC |
LEIDEN JEFFREY MDirector · President and COO
|
GrantCommon shares without par value | 100,000 | $44.16 | $4,416,000.00 |
DisclosureSEC source: 0001104659-06-011235 · a4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403,247 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:59 UTC |
Schumacher Laura JSenior Vice President
|
GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011236 · a4.xml · derivative · entry 4 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common shares · 83,000 shares Expires 2016-02-16 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/17/2007, 27,667 on 02/17/2008 and 27,666 on 02/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:59 UTC |
Schumacher Laura JSenior Vice President
|
GrantCommon shares without par value | 26,500 | $44.16 | $1,170,240.00 |
DisclosureSEC source: 0001104659-06-011236 · a4.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,131 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 23:00 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
GrantOption (right to buy) · Derivative | 310,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011237 · a4.xml · derivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,000 Underlying: common shares · 310,000 shares Expires 2016-02-16 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) Rule 16b-3. The option becomes exercisable in annual increments of 103,334 on 2/17/2007, 103,333 on 2/17/2008 and 103,333 on 2/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 23:00 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
GrantCommon shares without par value | 100,000 | $44.16 | $4,416,000.00 |
DisclosureSEC source: 0001104659-06-011237 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,160 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 23:18 UTC |
LIEPMANN HOLGER ASenior Vice President
|
GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011242 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common shares · 83,000 shares Expires 2016-02-16 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/17/2007, 27,667 on 02/17/2008 and 27,666 on 02/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 23:18 UTC |
LIEPMANN HOLGER ASenior Vice President
|
GrantCommon shares without par value | 26,500 | $44.16 | $1,170,240.00 |
DisclosureSEC source: 0001104659-06-011242 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,388 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 23:20 UTC |
ASHLEY RICHARD WExecutive Vice President
|
GrantCommon shares without par value | 55,000 | $44.16 | $2,428,800.00 |
DisclosureSEC source: 0001104659-06-011243 · a4.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,500 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:03 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 9,738 | $0.00 Strike: $43.73 | $0.00 |
DisclosureSEC source: 0001104659-06-010253 · a4.xml · derivative · entry 12 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,738 Underlying: common shares · 9,738 shares Expires 2008-02-12 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:03 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 11,383 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-06-010253 · a4.xml · derivative · entry 11 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,875 Underlying: common shares · 11,383 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:03 UTC |
Landgraf John CSenior Vice President
|
Tax withholdingCommon shares without par value | 9,738 | $43.73 | $425,842.74 |
DisclosureSEC source: 0001104659-06-010253 · a4.xml · nonDerivative · entry 5 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,631 Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:03 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 11,383 | $34.77 | $395,817.64 |
DisclosureSEC source: 0001104659-06-010253 · a4.xml · nonDerivative · entry 4 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,369 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:03 UTC |
Landgraf John CSenior Vice President
|
SaleCommon shares without par value | 637 | $43.49 | $27,703.13 |
DisclosureSEC source: 0001104659-06-010253 · a4.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,986 Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:09 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 29,245 | $0.00 Strike: $43.73 | $0.00 |
DisclosureSEC source: 0001104659-06-010254 · a4.xml · derivative · entry 9 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,245 Underlying: common shares · 29,245 shares Expires 2013-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:09 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 35,468 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-010254 · a4.xml · derivative · entry 8 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 35,468 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:09 UTC |
FREYMAN THOMAS CExecutive Vice President
|
SaleCommon shares without par value | 780 | $43.85 | $34,203.00 |
DisclosureSEC source: 0001104659-06-010254 · a4.xml · nonDerivative · entry 3 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,665 Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:09 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 29,245 | $43.73 | $1,278,883.85 |
DisclosureSEC source: 0001104659-06-010254 · a4.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,445 Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:09 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 35,468 | $33.23 | $1,178,651.30 |
DisclosureSEC source: 0001104659-06-010254 · a4.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,690 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:11 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
GrantOption (right to buy) · Derivative | 11,754 | $0.00 Strike: $43.73 | $0.00 |
DisclosureSEC source: 0001104659-06-010255 · a4.xml · derivative · entry 9 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,754 Underlying: common shares · 11,754 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:11 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 14,113 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-010255 · a4.xml · derivative · entry 8 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,470 Underlying: common shares · 14,113 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:11 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
SaleCommon shares without par value | 339 | $44.07 | $14,939.73 |
DisclosureSEC source: 0001104659-06-010255 · a4.xml · nonDerivative · entry 3 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,810 Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:11 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Tax withholdingCommon shares without par value | 11,754 | $43.73 | $514,002.42 |
DisclosureSEC source: 0001104659-06-010255 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,149 Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:11 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Exercise / conversionCommon shares without par value | 14,113 | $33.23 | $468,994.75 |
DisclosureSEC source: 0001104659-06-010255 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:17 UTC |
LIEPMANN HOLGER ASenior Vice President
|
GrantOption (right to buy) · Derivative | 2,286 | $0.00 Strike: $43.73 | $0.00 |
DisclosureSEC source: 0001104659-06-010258 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,286 Underlying: Common shares · 2,286 shares Expires 2008-02-12 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:17 UTC |
LIEPMANN HOLGER ASenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,875 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-06-010258 · a4.xml · derivative · entry 6 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,875 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:17 UTC |
LIEPMANN HOLGER ASenior Vice President
|
Tax withholdingCommon shares without par value | 2,286 | $43.73 | $99,966.78 |
DisclosureSEC source: 0001104659-06-010258 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,801 Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:17 UTC |
LIEPMANN HOLGER ASenior Vice President
|
Exercise / conversionCommon shares without par value | 2,875 | $34.77 | $99,971.51 |
DisclosureSEC source: 0001104659-06-010258 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.